Read + Share
Amedeo Smart
Independent Medical Education
Cleary JM, Horick NK, McCleary NJ, Abrams TA, et al. FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. Cancer 2019;125:2213-2221.PMID: 30913304
Email
LinkedIn
Facebook
Twitter
Privacy Policy